|

Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes

RECRUITINGN/ASponsored by University of Faisalabad
Actively Recruiting
PhaseN/A
SponsorUniversity of Faisalabad
Started2025-10-01
Est. completion2026-03-01
Eligibility
Age10 Years – 45 Years
Healthy vol.Accepted

Summary

The aim of this clinical trial is to learn if omega-3 fatty acid supplements help maintain healthy blood vessels in the eyes of adults with type 1 diabetes. It will also learn about the safety of omega-3 supplements. The main questions it aims to answer are: Do omega-3 supplements improve the health of retinal blood vessels in adults with type 1 diabetes? Are there any side effects when taking omega-3 supplements? Researchers will compare participants taking omega-3 supplements to a control group (if applicable) to see if the supplements help support retinal blood vessel health. Participants will: Take a daily omega-3 supplement for the duration of the study Attend regular eye exams to monitor changes in the retina Report any side effects or health changes during the study

Eligibility

Age: 10 Years – 45 YearsHealthy volunteers accepted
Inclusion Criteria:

Diagnosis of Type 1 Diabetes Age between 10 and 45 years Duration of diabetes ≥ 2 years Mild to moderate diabetic retinopathy allowed (based on fundus examination)

Exclusion Criteria:

Presence of any ocular disease other than diabetic retinopathy Use of medications that may affect retinal vascular measurements or visual function outcomes Presence of systemic diseases other than diabetes (e.g., uncontrolled hypertension, autoimmune diseases) History of ocular surgery within the past 6 months Current participation in another interventional clinical trial

Conditions4

DiabetesDiabetic RetinopathyOmega 3 Fatty AcidsType 1 Diabetes

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.